Acute leukemia of ambiguous lineage
Clinical trials for Acute leukemia of ambiguous lineage explained in plain language.
Never miss a new study
Get alerted when new Acute leukemia of ambiguous lineage trials appear
Sign up with your email to follow new studies for Acute leukemia of ambiguous lineage, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could removing certain immune cells prevent a deadly transplant complication?
Disease control OngoingThis study tests whether removing a specific type of immune cell (naive T cells) from donor stem cells can prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers. GVHD occurs when donor cells attack the patient's body after a stem cell tr…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for tough leukemia: experimental drug targets genetic flaw
Disease control OngoingThis study tests a new drug called ziftomenib (KO-539) in people with acute myeloid leukemia (AML) that has come back or not responded to treatment. The drug targets a specific genetic change (MLL rearrangement or NPM1 mutation) found in some patients. The goal is to find the saf…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase 1/2 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo aims to speed immune recovery after stem cell transplant
Disease control OngoingThis study tests whether giving palifermin and leuprolide acetate can help the immune system recover more quickly after a stem cell transplant for blood cancers like leukemia and lymphoma. About 82 participants will receive these drugs alongside their transplant. The goal is to s…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug cocktail shows promise for tough childhood leukemia
Disease control OngoingThis trial is testing whether adding two targeted drugs, venetoclax and navitoclax, to standard chemotherapy can help children and young adults with acute lymphoblastic leukemia (ALL) that has come back or not responded to treatment. The study has two phases: first, finding the b…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase 1/2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC